IDEXX Laboratories, Inc. IDXX

NASDAQ · Healthcare · Medical - Diagnostics & Research

$676.21

Close on Fri, 20 Nov 2026 · market value $53.3B

What the price is betting on

Priced for a lot to go right

At $676, the price assumes revenue grows about 25% a year for five years, from $4.7B to about $12B by FY2030. That is about three times what analysts expect for the next two years and about three times the company's own last three years.

The price assumes25%
Analysts, next two years8.8%
Last 3 years9.2%

Revenue growth a year. The price figure comes from a reverse DCF at a 11% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than IDXX? Check up to 5 of your stocks at once, free, no account.

0$5B$10B$15B$4.7B'22'23'24'25Sep '26'26'27'28'29'30What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$245

Base

$297

Bull

$359

Today $676

  • Bear $245. Cash flow grows 5% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $297. Cash flow grows 9% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $359. Cash flow grows 13% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$4.9B$4.7B, below the path
  3. FY2027$6.2B$5.2B, below the path
  4. FY2028$7.7B$5.7B, below the path
  5. FY2029$9.6B$6.2B, below the path
  6. FY2030$12B$6.8B, below the path

Each year's revenue at 25% growth from $4.7B in the 12 months to September 2026.

At a glance

Healthcare · Medical - Diagnostics & Research · listed on NASDAQ

Revenue, FY2025
$4.3B
Growth, 3 years a year
9.2%
Cash margin
25%
Net debt
$897M
Shares, 3-year change
−4.6%
Dividend yield
0%

What other healthcare prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.